CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Eocene Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Eocene Ltd
16 Abba Hillel Silver Rd.
Phone: +972 36938448p:+972 36938448 RAMAT GAN, 5250608  Israel Ticker: EOCNEOCN
Business Summary
EoCene Ltd., formerly Galmed Pharmaceuticals Ltd., is an Israel-based healthcare technology and biopharmaceutical company engaged in the development of therapeutic products, medical devices, and healthcare technologies. The Company focuses on gastrointestinal diseases, gastrointestinal oncology, and related medical conditions through a portfolio of pharmaceutical and medical device programs. Its activities include research, development, clinical evaluation, and commercialization of therapeutic candidates and medical technologies. The Company’s portfolio includes Aramchol, a therapeutic candidate for liver and oncology-related indications, and medical device technologies developed through its subsidiary Colospan Ltd. for gastrointestinal and colorectal applications. EoCene Ltd. conducts its operations through biopharmaceutical, medical device, and healthcare technology activities.
(Source: 6-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202612/31/2025YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Director AllenBaharaff 57
Chief Financial Officer DoronCohen 61 2/1/2022 2/1/2022
Chief Operating Officer, Data Protection Officer GuyNehemya 37 1/1/2021 3/1/2017
7 additional Officers and Directors records available in full report.

Business Names
Business Name
EOCN
Galmed International Ltd.
Galmed Research and Development Ltd.
5 additional Business Names available in full report.

General Information
Number of Employees: 3 (As of 12/31/2025)
Outstanding Shares: 1,041,565 (As of 8/19/2026)
Shareholders: 8
Stock Exchange: NASD
Federal Tax Id: 981147233
Fax Number: +972 36938447


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, October 27, 2026